A newly emergent N1 neuraminidase associated with clade 2.3.4.4b highly pathogenic avian influenza A(H5) viruses in North America

This study characterizes the evolutionary history and phylodynamics of a newly emergent North American N1 neuraminidase (am4N1) associated with H5N1 clade 2.3.4.4b viruses, revealing its distinct avian origin, introduction from western Canada, and conserved structural architecture despite sequence divergence that warrants further investigation into potential cross-reactivity with human A(H1N1)pdm09 immunity.

The Gist

The Big Picture: A New "Key" in the Bird Flu Locksmith Shop

Imagine the world of bird flu (specifically the H5N1 virus) as a massive, chaotic locksmith shop. For years, the shop has been making a specific type of key (the virus) that fits into a specific lock (birds and mammals). This key has a "handle" (the Hemagglutinin or HA part) and a "blade" (the Neuraminidase or NA part).

This paper is about a brand new, weirdly shaped blade that has suddenly appeared in North America. It's attached to a very dangerous bird flu virus, but the blade itself is a genetic mystery that scientists are just starting to understand.

1. The Mystery Guest: "am4N1"

For a long time, the bird flu viruses in North America had blades that looked like the ones found in European birds or the 2009 human swine flu. But in late 2024, scientists found two new virus strains (called D1.1 and D1.2) that had a completely different blade.

They named this new blade am4N1.

• The Analogy: Think of the virus as a car. The engine (HA) is the same dangerous H5N1 engine everyone knows. But the transmission (NA) is a completely different model. It's like putting a vintage 1970s transmission into a modern sports car. It works, but it's totally unique.

2. Where did it come from? (The Family Tree)

Scientists traced the family tree of this new blade.

• The Discovery: They found out this blade didn't come from Europe or the 2009 human flu. It actually comes from North American wild ducks and geese.
• The Story: For decades, this specific blade was hiding out in wild waterfowl, usually paired with a very mild flu virus (H1N1). It was like a quiet librarian living in the back of a library.
• The Switch: Sometime around late 2023 or early 2024, a wild bird got infected with two flu viruses at once: the deadly H5 bird flu and the mild H1 flu. They swapped parts (a process called reassortment). The deadly H5 virus grabbed the new "am4N1" blade from the mild virus.
• The Result: Now, the deadly bird flu has a new, unique blade that humans have never seen before.

3. The "Stalk" Problem: The Virus is Getting Shorter

As this new virus spread from Canada down into the US and Mexico, it started changing.

• The Analogy: Imagine the virus blade has a long handle (the "stalk") that holds it up. As the virus jumped from wild birds into chickens and turkeys (poultry), it started cutting pieces off its handle.
• Why? In the world of flu viruses, cutting off the handle is often a sign that the virus is getting better at infecting farm animals. It's like a runner shedding heavy boots to run faster on a specific track.
• The Danger: We saw this happen in wild birds, but then it started happening in farm birds and even mammals (like cats and minks). This suggests the virus is adapting to live in different animals.

4. Why Should We Care? (The Human Risk)

This is the most critical part of the paper.

• The Immunity Gap: Humans have built up some immunity to bird flu because we've been exposed to the 2009 H1N1 flu (the "swine flu" pandemic) and seasonal flu shots. Our bodies have antibodies (defense soldiers) that recognize the old blades.
• The Problem: Because this new am4N1 blade is so different from the old ones, our defense soldiers might not recognize it. It's like the virus changed its uniform.
• The Evidence: The paper notes that while most recent bird flu cases in humans have been mild, the cases caused by this new D1.1 strain (with the am4N1 blade) have been much more severe. Two people died, and others got very sick.
• The Question: The scientists are asking: Does our current flu shot protect us against this new, weird blade? Right now, the answer is "we don't know yet, but we are worried."

5. The "Lockpick" (Drug Resistance)

There is a common flu drug called Oseltamivir (Tamiflu) that works by jamming the virus's blade so it can't spread.

• Good News: So far, most of these new viruses are still sensitive to Tamiflu.
• Bad News: One specific sample from Canada was found to have a tiny mutation that makes it resistant to the drug. Scientists are watching this closely, like a security guard watching for a master key.

Summary: What's Next?

This paper is a warning and a map.

1. The Map: It tells us exactly where this new virus came from (North American ducks) and how it got here (swapping parts with other flu viruses).
2. The Warning: This new virus has a "face" (the blade) that our immune systems might not recognize, which could make it more dangerous to humans.
3. The Call to Action: We need to study this new blade immediately. We need to check if our current vaccines work against it and keep watching to see if it gets better at infecting people.

In short: A dangerous bird flu virus has found a new, unique key in North America. It's spreading fast, changing its shape to fit new hosts, and we aren't sure if our current defenses will stop it. Scientists are racing to understand this new player before it becomes a bigger threat.

Technical Summary

1. Problem Statement

Since 2021, Highly Pathogenic Avian Influenza (HPAI) A(H5N1) clade 2.3.4.4b has caused a massive epizootic in North America, leading to unprecedented mortality in wild birds, the depopulation of over 100 million poultry, and spillover into mammals. In late 2024, two novel genotypes, D1.1 and D1.2, emerged in the Pacific Northwest. These viruses carry a unique neuraminidase (NA) gene, designated am4N1, which differs significantly from the Eurasian N1 lineages previously associated with HPAI in the Americas.

The emergence of am4N1 is critical because:

• It has been linked to severe human disease and fatalities (including the first H5N1 death in the US and a child in Mexico), whereas previous genotypes (e.g., B3.13) caused milder symptoms.
• The evolutionary origin and structural characteristics of am4N1 are distinct from human seasonal N1s (A(H1N1)pdm09), raising concerns about whether prior human immunity (via vaccination or infection) offers cross-protection.
• There is a need to understand the phylogeography, evolutionary history, and structural implications of this new NA lineage to assess pandemic risk.

2. Methodology

The study employed a comprehensive bioinformatic and structural biology approach:

• Sequence Acquisition & Curation:
  • Used A/Washington/255/2024 (an early D1.1 isolate) as a reference to search GISAID and NCBI SRA databases.
  • Filtered sequences based on genetic distance (TN93 < 0.1) to define the am4N1-like dataset (2,061 sequences).
  • Created a Global N1 dataset (136,205 sequences, reduced to 844 non-redundant representatives at 98% identity) to contextualize am4N1 within global diversity.
• Phylogenetics & Phylodynamics:
  • Constructed Maximum Likelihood trees using IQtree2 with the GTR+F+R7 substitution model.
  • Performed time-scaled phylogenetic analysis using TreeTime and augur to estimate the Time to Most Recent Common Ancestor (TMRCA) and substitution rates.
  • Tracked host associations and geographic spread.
• Structural Biology:
  • Selected representative sequences for AlphaFold3 protein structure prediction.
  • Refined the globular head domain (residues 80–479) using Rosetta relax protocols to minimize steric clashes.
  • Calculated Root Mean Square Deviation (RMSD) and analyzed surface accessibility of residues near the enzymatic active site.
• Domain Analysis:
  • Specifically investigated the stalk domain for deletions, which are known markers of host adaptation.

3. Key Results

Phylogenetic Origin and Evolution

• Distinct Lineage: am4N1 forms a monophyletic clade sister to Eurasian avian, swine, and human A(H1N1)pdm09 viruses, but is distinct from 1918, pre-2009 seasonal, and classical swine N1 lineages.
• Ancestry: The lineage descends from diverse avian N1 genes endemic to the Americas, specifically associated with avian A(H1) viruses circulating in North American migratory waterfowl (e.g., mallards).
• Emergence: The TMRCA for the am4N1 clade is estimated at January 2023. The virus likely circulated undetected in wild birds until late 2024, when it reassorted with HPAI A(H5) clade 2.3.4.4b hemagglutinin (HA) in western Canada before spreading to the US and Mexico.
• Genetic Markers: The clade is defined by specific mutations, including NA:S82P, T244C, and C588T.

Stalk Domain Deletions

• Seven instances of stalk deletions were identified in the am4N1 clade, ranging from 17 to 27 amino acids.
• Host Adaptation: These deletions are predominantly observed in wild birds but are also found in farmed animals (poultry, felines). Ancestral node reconstruction suggests these deletions often arise in poultry hosts, indicating adaptation to gallinaceous species.
• Convergent Evolution: The deletion SΔAA:53-78 appeared in two separate subclades, suggesting convergent evolution.

Structural Analysis

• Conserved Architecture: Despite significant amino acid divergence (approx. 30–50 residues different from Eurasian N1s and ~66 from A(H1N1)pdm09), the globular head structure remains highly conserved (low RMSD).
• Critical Substitution: A single amino acid substitution, N221S (N2 numbering N220), was identified in the am4N1 lineage. This residue is located near the enzymatic active site and is a known site for monoclonal antibody escape. Surface accessibility mapping confirms this site is exposed.

Epidemiological Context

• The D1.1 genotype (carrying am4N1) has caused severe disease and fatalities in humans (Washington, Louisiana, Wyoming, Mexico) and spillover into dairy cattle.
• In contrast, genotype B3.13 (carrying Eurasian N1) has caused mostly mild human infections.

4. Key Contributions

1. Evolutionary Context: The study definitively traces the origin of the dangerous D1.1/D1.2 genotypes to a reassortment event between HPAI A(H5) and a North American avian A(H1) virus carrying the am4N1 gene.
2. Structural Characterization: It provides the first high-confidence structural models of am4N1, demonstrating that while the sequence is divergent, the overall fold is conserved, but specific surface-exposed residues (like N221S) may alter antigenicity.
3. Host Adaptation Evidence: It documents the rapid acquisition of stalk deletions in the am4N1 lineage as the virus spreads from wild birds to poultry and mammals, a hallmark of host range expansion.
4. Public Health Warning: It highlights a potential gap in human immunity. Since am4N1 is phylogenetically distant from the N1 in seasonal vaccines (A(H1N1)pdm09), prior immunity may not offer effective cross-protection, potentially explaining the severity of D1.1 infections compared to B3.13.

5. Significance

This research underscores the dynamic nature of HPAI evolution in North America. The emergence of am4N1 represents a significant shift in the pandemic threat landscape:

• Vaccine Mismatch Risk: The divergence of am4N1 from human seasonal N1s suggests that current seasonal influenza vaccines may offer limited protection against severe disease caused by D1.1 viruses.
• Therapeutic Implications: While most am4N1 viruses remain susceptible to neuraminidase inhibitors (oseltamivir), the study notes the presence of the H275Y resistance marker in some Canadian isolates, necessitating continued surveillance.
• Surveillance Priority: The identification of the N221S substitution and the pattern of stalk deletions provides specific molecular targets for monitoring viral fitness, host adaptation, and immune escape in future outbreaks.

The authors conclude that detailed studies on human antibody recognition of am4N1 are urgently needed to refine pandemic preparedness strategies.